C12N 2710/14043
Viral genome or elements thereof as genetic vectore
Official title: viral genome or elements thereof as genetic vectore
C12N2710/14043 (Viral genome or elements thereof as genetic vectore) appears on 138 US grants and 222 published applications in this corpus.
Search patents in C12N- Granted patents
- 138
- Published applications
- 222
- Assignees
- 145
- Inventors
- 435
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 3 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 0 |
| 2003 | 1 | 4 |
| 2004 | 2 | 2 |
| 2005 | 1 | 2 |
| 2006 | 1 | 3 |
| 2007 | 2 | 3 |
| 2008 | 0 | 6 |
| 2009 | 4 | 7 |
| 2010 | 0 | 4 |
| 2011 | 5 | 8 |
| 2012 | 2 | 6 |
| 2013 | 4 | 4 |
| 2014 | 0 | 8 |
| 2015 | 7 | 18 |
| 2016 | 8 | 15 |
| 2017 | 9 | 17 |
| 2018 | 16 | 8 |
| 2019 | 8 | 12 |
| 2020 | 12 | 18 |
| 2021 | 8 | 16 |
| 2022 | 3 | 13 |
| 2023 | 8 | 10 |
| 2024 | 9 | 15 |
| 2025 | 7 | 15 |
| 2026 | 7 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant adeno-associated virus compositions and methods for producing same8 Sep 2026US 12,729,385 B2Prevail Therapeutics, Inc.
- Baculovirus expression system28 Jul 2026US 12,692,481 B2Virovek, Inc.
- SmartBac baculovirus expression system and application thereof9 Jun 2026US 12,649,931 B2Institute of Biophysics, Chinese Pie Academy of Sciences
- Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals2 Jun 2026US 12,642,831 B2MangoGen Pharma, Inc.
- Method of enabling pooled-library based nucleic acid constructs screening2 Jun 2026US 12,644,117 B2Leadxpro AG
- Engineered tet enzymes and use in epigenetics and next generation sequencing (ngs), such as tet-assisted pyridine borane sequencing (taps)1 Oct 2026US 2026/0297543 A1Exact Sciences Innovation LTD.
- Generation of adeno-associated virus capsid libraries for insect cells10 Sep 2026US 2026/0265729 A1uniQure biopharma B.V.
- Gene therapies for lysosomal disorders27 Aug 2026US 2026/0250715 A1Prevail Therapeutics, Inc.
- Further improved aav vectors produced in insect cells23 Jul 2026US 2026/0209798 A1uniQure IP B.V.
- Method for preparing corona virus-like particles and vaccine comprising the same16 Jul 2026US 2026/0201414 A1National Defense Medical University
Most cited
By later US patents
- Penton base protein and methods of using same136US 5,559,099 AGenVec, Inc. · 1996
- Parvovirus protein presenting capsids66US 5,916,563 AUnited States of America · 1999
- Adenoviral-mediated cell targeting commanded by the adenovirus penton base protein58US 5,712,136 AGenVec, Inc. · 1998
- Penton base protein and methods of using same50US 5,731,190 AGenVec, Inc. · 1998
- Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV45US 8,512,981 B2Amsterdam Molecular Therapeutics B.V. · 2013